Mya Tran(@MyaPrecisionG) 's Twitter Profile Photo

Could this be another agnostic approval of TDXd? (0.3-12% in solid tumors - TCGA)
🔼ORR 29.4%; PFS 5.4 ms
👍Activity seen across tumor types, strongest signal in breast, bladder, salivary
👍Mutant location doesn't seem to matter?

Could this be another agnostic approval of TDXd? #HER2mutant (0.3-12% in solid tumors - TCGA) #DestinyPanTumor1 #PrecisionOncology 
🔼ORR 29.4%; PFS 5.4 ms 
👍Activity seen across tumor types, strongest signal in breast, bladder, salivary
👍Mutant location doesn't seem to matter?
account_circle
Lumanity(@lumanity) 's Twitter Profile Photo

The recent Emerging Frontiers in Oncology Summit explored the future of , exploring research, innovation, and the people behind it all. Check out the highlights and insights at buff.ly/44mXEkE

The recent Emerging Frontiers in Oncology Summit explored the future of #precisiononcology, exploring research, innovation, and the people behind it all. Check out the highlights and insights at buff.ly/44mXEkE

#oncology #researchandinnovation #cancer #EmergingFrontiers
account_circle
PRIME-ROSE(@PRIMEROSE_EU) 's Twitter Profile Photo

PRIME-ROSE vision aims to make PCM accessible and affordable to all cancer patients. Our collaboration and brings us closer. Read more from the latest news splash lnkd.in/e5bfhFzH

account_circle